Genzyme Corp acquires Wyeth- Sales,Marketing Rights from Wyeth


US - Genzyme Corp acquired the sales and marketing rights to Synvisc (R) (hylan G-F ##) from Wyeth, a manufactrurer of pharmaceutical products, for $### mil. The consideration consisted of $### mil in cash and up to $### mil in

Deal Information

Credit & Investment Research

Market Research

News